128 related articles for article (PubMed ID: 1712346)
1. Peptide-mediated allo-recognition of HLA-B27 by cytotoxic T lymphocytes.
Rojo S; López de Castro JA
Int J Cancer Suppl; 1991; 6():10-3. PubMed ID: 1712346
[TBL] [Abstract][Full Text] [Related]
2. Conservation and alteration of HLA-B27-specific T cell epitopes on mouse cells. Implications for peptide-mediated alloreactivity.
Rojo S; López D; Calvo V; López de Castro JA
J Immunol; 1991 Jan; 146(2):634-42. PubMed ID: 1702810
[TBL] [Abstract][Full Text] [Related]
3. Cross-reactive T cell clones from unrelated individuals reveal similarities in peptide presentation between HLA-B27 and HLA-DR2.
López D; Barber DF; Villadangos JA; López de Castro JA
J Immunol; 1993 Apr; 150(7):2675-86. PubMed ID: 7681078
[TBL] [Abstract][Full Text] [Related]
4. Specificity and frequency of primary anti-HLA cytotoxic T lymphocytes in normal and HLA-B27.2-, HLA-B27.5-, and HLA-Cw3-transgenic mice. A transgenic model for MHC xenoantigen recognition.
Kievits F; Boerenkamp WJ; Lokhorst W; Ivanyi P
J Immunol; 1990 Jun; 144(12):4513-9. PubMed ID: 2351823
[TBL] [Abstract][Full Text] [Related]
5. Analysis of HLA B27 in ankylosing spondylitis with human alloreactive cytolytic T lymphocyte clones: failure to detect disease-related T cell epitopes.
Czitrom AA; Pototschnik R; Edwards S; Gladman DD; Falk JA
Exp Clin Immunogenet; 1986; 3(3):129-37. PubMed ID: 2484102
[TBL] [Abstract][Full Text] [Related]
6. Recognition of HLA-B27 by mouse cytotoxic T-cell clones: a transgenic mouse model.
Reboul M; Frangoulis B; Rocca A; Degos L; Pla M
Immunogenetics; 1991; 34(3):196-200. PubMed ID: 1894313
[TBL] [Abstract][Full Text] [Related]
7. Avidity dictates the lytic capacity of human cytolytic T lymphocyte clones with similar fine specificity against murine cells expressing HLA-B27 antigen.
Calvo V; Rojo S; Aparicio P; Galocha B; López de Castro JA
J Immunol; 1988 Dec; 141(11):3798-803. PubMed ID: 2460549
[TBL] [Abstract][Full Text] [Related]
8. Clonal heterogeneity in LFA-3 and ICAM-1 requirement for lysis by alloreactive T lymphocytes.
Galocha B; López D; López de Castro JA
J Immunol; 1993 Mar; 150(5):1653-62. PubMed ID: 7679690
[TBL] [Abstract][Full Text] [Related]
9. Effect of a Tyr-to-His point-mutation at position 59 in the alpha-1 helix of the HLA-B27 class-I molecule on allospecific and virus-specific cytotoxic T-lymphocyte recognition.
Breur-Vriesendorp BS; Vingerhoed J; Kuijpers KC; van der Horst AR; de Waal LP; Kievits F; Ivanyi P
Scand J Rheumatol Suppl; 1990; 87():36-43. PubMed ID: 1701919
[TBL] [Abstract][Full Text] [Related]
10. Structure and diversity of HLA-B27-specific T cell epitopes. Analysis with site-directed mutants mimicking HLA-B27 subtype polymorphism.
Calvo V; Rojo S; López D; Galocha B; López de Castro JA
J Immunol; 1990 May; 144(10):4038-45. PubMed ID: 1692072
[TBL] [Abstract][Full Text] [Related]
11. Role of binding pockets for amino-terminal peptide residues in HLA-B27 allorecognition.
Villadangos JA; Galocha B; López D; Calvo V; López de Castro JA
J Immunol; 1992 Jul; 149(2):505-10. PubMed ID: 1378067
[TBL] [Abstract][Full Text] [Related]
12. Strong memory CD8+ T cell responses against immunodominant and three new subdominant HLA-B27-restricted influenza A CTL epitopes following secondary infection of HLA-B27 transgenic mice.
Cheuk E; Chamberlain JW
Cell Immunol; 2005 Apr; 234(2):110-23. PubMed ID: 16054612
[TBL] [Abstract][Full Text] [Related]
13. Effect of the substitution of critical residues on the allorecognition of HLA-B27.
Ozen S; Clayberger C; Krensky AM; Benjamin R
Clin Exp Rheumatol; 1992; 10(6):583-7. PubMed ID: 1282853
[TBL] [Abstract][Full Text] [Related]
14. Peptide-presenting similarities among functionally distant HLA-B27 subtypes revealed by alloreactive T lymphocytes of unusual specificity.
López D; Rojo S; Calvo V; López de Castro JA
J Immunol; 1992 Feb; 148(4):996-1002. PubMed ID: 1371137
[TBL] [Abstract][Full Text] [Related]
15. Fine specificity of HLA-B27 cellular allorecognition. HLA-B27f is a functional variant distinguishable by cytolytic T cell clones.
Aparicio P; Rojo S; Jaraquemada D; López de Castro JA
J Immunol; 1987 Aug; 139(3):837-41. PubMed ID: 2439595
[TBL] [Abstract][Full Text] [Related]
16. HLA-B27-restricted cytotoxic T lymphocyte responses to arthritogenic enterobacteria or self-antigens are dominated by closely related TCRBV gene segments. A study in patients with reactive arthritis.
Duchmann R; May E; Ackermann B; Goergen B; Meyer zum Büschenfelde KH; Märker-Hermann E
Scand J Immunol; 1996 Jan; 43(1):101-8. PubMed ID: 8560188
[TBL] [Abstract][Full Text] [Related]
17. Different HLA-B27 subtypes present the same immunodominant Epstein-Barr virus peptide.
Brooks JM; Murray RJ; Thomas WA; Kurilla MG; Rickinson AB
J Exp Med; 1993 Sep; 178(3):879-87. PubMed ID: 7688791
[TBL] [Abstract][Full Text] [Related]
18. Recognition of chlamydial antigen by HLA-B27-restricted cytotoxic T cells in HLA-B*2705 transgenic CBA (H-2k) mice.
Kuon W; Lauster R; Böttcher U; Koroknay A; Ulbrecht M; Hartmann M; Grolms M; Ugrinovic S; Braun J; Weiss EH; Sieper J
Arthritis Rheum; 1997 May; 40(5):945-54. PubMed ID: 9153558
[TBL] [Abstract][Full Text] [Related]
19. TCRB junctional regions from HLA-B27-restricted T cells and HLA-B27 binding peptides display conserved hydropathy profiles in the absence of primary sequence homology.
May E; Duchmann R; Ackermann B; Meyer zum Büschenfelde KH; Märker-Hermann E
Int Immunol; 1996 Nov; 8(11):1815-23. PubMed ID: 8943577
[TBL] [Abstract][Full Text] [Related]
20. Cross-reactivity among evolutionarily distant major histocompatibility complex class I molecules (HLA-B27 and H-2Kk) revealed by xenoreactive T lymphocytes.
Frangoulis B; Reboul M; Rocca A; Pla M
Eur J Immunol; 1993 Feb; 23(2):338-42. PubMed ID: 8436169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
